GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Cash Ratio

Wright Medical Group NV (Wright Medical Group NV) Cash Ratio : 0.16 (As of Sep. 2020)


View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Wright Medical Group NV's Cash Ratio for the quarter that ended in Sep. 2020 was 0.16.

Wright Medical Group NV has a Cash Ratio of 0.16. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Wright Medical Group NV's Cash Ratio or its related term are showing as below:

WMGI's Cash Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.23
* Ranked among companies with meaningful Cash Ratio only.

Wright Medical Group NV Cash Ratio Historical Data

The historical data trend for Wright Medical Group NV's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Cash Ratio Chart

Wright Medical Group NV Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 0.55 0.40 0.41 0.20

Wright Medical Group NV Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.20 0.13 0.16 0.16

Competitive Comparison of Wright Medical Group NV's Cash Ratio

For the Medical Devices subindustry, Wright Medical Group NV's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group NV's Cash Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's Cash Ratio falls into.



Wright Medical Group NV Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Wright Medical Group NV's Cash Ratio for the fiscal year that ended in Dec. 2019 is calculated as:

Cash Ratio (A: Dec. 2019 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=166.856/850.008
=0.20

Wright Medical Group NV's Cash Ratio for the quarter that ended in Sep. 2020 is calculated as:

Cash Ratio (Q: Sep. 2020 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=141.549/907.803
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wright Medical Group NV  (NAS:WMGI) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Wright Medical Group NV Cash Ratio Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group NV (Wright Medical Group NV) Business Description

Traded in Other Exchanges
N/A
Address
Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.
Executives
Steven P. Wallace officer: President, International 1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan officer: SVP, Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith officer: SVP, Quality and Regulatory 1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper officer: SVP, Chief Digital Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier officer: President, Upper Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher officer: President, Lower Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter officer: SVP, Chief Compliance Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews officer: SVP, Global Finance 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker officer: SVP, Process Improvement 5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton officer: SVP, Chief Human Resources Ofr 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry officer: EVP, Chief Finan./Op. Officer 5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey officer: SVP, Chief Comm. Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell officer: EVP, Chief Global Comm Officer C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano director, officer: President and Chief Executive 110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke officer: Pres. Emerging Markets AUS/JAP 5677 AIRLINE ROAD ARLINGTON TN 38002

Wright Medical Group NV (Wright Medical Group NV) Headlines

From GuruFocus

Keeley Asset Management Comments on Wright Medical Group

By Sydnee Gatewood Sydnee Gatewood 10-15-2019